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It is unclear whether acid-base balance disturbances during the perioperative period may
impact Clostridium difficile infection (CDI), which is the third most common major infection
following cardiac surgery. We hypothesized that perioperative acid-base abnormalities
including lactate disturbances may predict the probability of incidence of CDI in patients
after cardiac procedures.
Methods
Of the 12,235 analyzed patients following cardiac surgery, 143 (1.2%) developed CDI. The
control group included 200 consecutive patients without diarrhea, who underwent cardiac
procedure within the same period of observation. Pre-, intra and post-operative levels of
blood gases, as well as lactate and glucose concentrations were determined. Postopera-
tively, arterial blood was drawn four times: immediately after surgery and successively; 4, 8
and 12 h following the procedure.
Results
Baseline pH was lower and PaO2 was higher in CDI patients (p < 0.001 and p = 0.001,
respectively). Additionally, these patients had greater base deficiency at each of the ana-
lyzed time points (p < 0.001, p = 0.004, p = 0.012, p = 0.001, p = 0.016 and p = 0.001,
respectively). Severe hyperlactatemia was also more common in CDI patients; during the
cardiac procedure, 4 h and 12 h after surgery (p = 0.027, p = 0.004 and p = 0.001, respec-
tively). Multivariate logistic regression analysis revealed that independent risk factors for
CDI following cardiac surgery were as follows: intraoperative severe hyperlactatemia (OR
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2.387, 95% CI 1.155–4.933, p = 0.019), decreased lactate clearance between values imme-
diately and 12 h after procedure (OR 0.996, 95% CI 0.994–0.999, p = 0.013), increased age
(OR 1.045, 95% CI 1.020–1.070, p < 0.001), emergent surgery (OR 2.755, 95% CI 1.565–
4.848, p < 0.001) and use of antibiotics other than periprocedural prophylaxis (OR 2.778,
95% CI 1.690–4.565, p < 0.001).
Conclusion
This study is the first to show that perioperative hyperlactatemia and decreased lactate
clearance may be predictors for occurrence of CDI after cardiac surgery.
Introduction
Clostridioides difficile (CD) is an anaerobic, Gram-positive bacillus, which may be part of the
normal intestinal microbiota in healthy people. However, approximately 15% of adults experi-
ence colonization by CD and the prevalence is several times higher in hospitalized patients
and in long-term care facilities residents [1]. CD is the most common cause of hospital-
acquired diarrhea leading to increased morbidity and mortality in surgical patients [2]. In the
last decades, the incidence of Clostridium difficile infection (CDI) has increased markedly
worldwide [3, 4]. CDI is the third most common major infection (after pneumonia and blood-
stream infections) following cardiac surgery [5].
There are many well-established risk factors for CDI development. These may include host
factors (immune status, comorbidities), exposure to CD spores (hospitalizations) and other
factors that disrupt normal colonic microbiome (antibiotics and other medications or surgery)
[6]. It has also been shown that high glucose levels and stress hyperglycemia during the early
postoperative period were associated with greater risk for development of CDI in patients fol-
lowing cardiac surgery [7]. It is unclear whether other acid-base disturbances, especially the
development of hyperlactatemia in the perioperative period, may impact CDI occurrence.
Hyperlactatemia is a common occurrence in cardiac surgery and affects about 10 to 20% of
patients [8]. Lactate is a product of pyruvate reduction by the enzyme lactate dehydrogenase
during glycolysis. It is produced during physiological processes and is cleared by the liver and
the kidney. However, in critically conditions associated with tissue hypoxia and anaerobic
metabolism, pyruvate is accumulated rapidly and its metabolism is shifted to lactate produc-
tion [9]. Hyperlactatemia can also result from reduced clearance, thus when increased produc-
tion of lactate coexists with decreased clearance, the severity of the hyperlactatemia escalates
[10]. An elevated lactate level can have profound hemodynamic consequences and is a well-
recognized marker of circulatory failure and tissue hypoxia [11, 12] as well as being a sensitive
and specific indicator of intestinal ischemia [13, 14]. Early onset of hyperlactatemia which
develops intraoperatively or within the first 6 hours after surgery is associated with an
increased risk for worse outcomes, prolonged hospital stay and death [8, 11, 12].
To the best of our knowledge, there have been no studies investigating the impact of acid-
base balance disturbances on CDI occurrence following cardiac surgery. In the present report
we tested the hypothesis that perioperative acid-base abnormalities, including lactate distur-
bances, may predict the probability of incidence of CDI in patients after cardiac procedures.
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Materials and methods
Patients
This retrospective study was conducted by reviewing the medical records of 12,235 adult
patients who underwent cardiac surgery in our institution from January 2014 to December
2019. The final study population comprised 143 patients who developed CDI during the post-
operative period. The control group included 200 consecutive patients without diarrhea, who
underwent cardiac surgery within the same period of observation. CDI was suspected in each
patient experiencing three or more unformed stools per day and it was defined as a combina-
tion of symptoms and signs of the disease and confirmed by microbiological evidence of
toxin-producing CD in the patients’ stools [15]. Stool samples were analyzed using the rapid
enzyme immunoassays test C, Diff Quik Chek Complete test (Techlab, Orlando, USA). Addi-
tionally, demographics, comorbidities, type and timing of cardiac surgery, perioperative infec-
tions and antibiotic treatment, readmission to intensive care unit and lastly in-hospital length
of stay were collected.
Each patient received periprocedural antimicrobial prophylaxis, based on the first genera-
tion of cephalosporin (cefazolin). This was continued for another 3 to 5 doses postoperatively.
Only in cases of history of allergy to cephalosporins or penicillin, clindamycin was
administered.
The study was performed in accordance with the Declaration of Helsinki. The study was
approved by the local Research Ethics Committee of the Andrzej Frycz Modrzewski Krakow
University (ID 10/2019), which waived the need for inform consent due to the retrospective
manner of analysis. Data were collected from Electronic Medical Records of John Paul II Hos-
pital in Krakow (Poland), between January and March 2020. Personal identifiable information
of the participants was anonymized upon extraction of the relevant data for the study, and
patients were coded using numbers (1, 2, or 3, and so on).
Laboratory investigations
Acid-base balance analyses were obtained from arterial lines that were placed in all patients
before the cardiac procedure. Blood gases (pH, PaCO2, PaO2, base excess (BE)) as well as lac-
tate and glucose concentrations were determined. Preoperative, intraoperative and postopera-
tive levels of these parameters were assessed. Postoperatively, arterial blood was drawn four
times: immediately after surgery and successively 4, 8 and 12 h following the procedure.
In our laboratory the reference ranges for normal values were as follows: for pH 7.35–7.45,
for PaCO2 35–45 mmHg, for PaO2 74–108 mmHg, for BE -2.5–+2.5 mEq/l, for serum lactate
concentration 0.5–1.6 mmol/l and for glucose concentration 3.9–5.5 mmol/l. The ranges were
based on internal laboratory standardization for acid-base balance analyses and measurements
were performed with ABL 835 FLEX blood gas analyzer (Radiometer Medical ApS, Brønshøj,
Denmark).
Hyperlactatemia was defined as a peak lactate value> 2 mmol/l. Severe hyperlactatemia
was diagnosed when peak lactate value was > 4 mmol/l based on our institution’s laboratory
reference ranges and a review of literature [8, 12, 16, 17]. Lactate clearance was calculated as
follows: [(lactate initial− lactate delayed) /lactate initial] x 100% [18]. In this study the lactate
clearances were calculated for the following intervals: between measurements preformed
immediately and 4 h after surgery, between 4 h and 8 h following procedure, between 8 h and
12 h post operation, between values immediately and 12 h following surgery and finally
between intraoperative values and 12 h after procedure.
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Stress hyperglycemia was defined as one or more blood sugar concentration > 180 mg/dl
(10 mmol/l) during the first 24 h of the postoperative course [5].
Statistical analysis
Statistical analysis was performed using the IBM1 SPSS1 Statistics 25. Normal distribution
was tested using the Kolmogorov-Smirnov and Shapiro-Wilk tests. Continuous variables were
presented as mean and standard deviations (±) or median and interquartile ranges when
appropriate. For categorical variables, numbers and proportions were reported. When appro-
priate, parametric and non-parametric tests were used for either independent samples (chi-
squared test, Mann-Whitney U test, t-test) or repeated measurements (McNemar’s test,
Wicoxon signed-rank test, Firedman test). For ordinal variables, two sample Kolmogorov-
Smirnov tests were used. Multivariate logistic regression model was calculated to determine
independent predictors for CDI. A 2-tailed p value of< 0.05 was considered to indicate statis-
tical significance.
Results
Of the 12,235 patients, 143 (1.2%) developed CDI. The CDI and control groups of analyzed
patients were comparable, however patients with CDI were older in comparison to the control
group (median age 71 vs 67, p< 0.001). Additionally, the CDI patients more often had a his-
tory of malignant neoplasms (p = 0.048) (Table 1).
Acid-base balance
As shown in Table 2, patients with CDI had lower values of pH during the whole observation
period, however, a significant difference was observed only during the preoperative period
(p< 0.001, compared with the control group). There was no difference between groups in
PaCO2 levels in any of the studied periods, while PaO2 was higher in CDI patients only at base-
line (p = 0.001). Furthermore, at each of the analyzed time points, patients with CDI had
greater base deficiency (more negative BE) (p< 0.001, p = 0.004, p = 0.012, p = 0.001,
p = 0.016 and p = 0.001, respectively compared with the control group).
Table 1. Baseline characteristics.
Variable Patients with CDI (n = 143) Patients without CDI (n = 200) p-value
Age, (years) 71 [64–77] 67 [61–72] <0.001
Male sex, n (%) 93 (65) 135 (67.5) 0.634
Comorbidities, n (%)
Hypertension 112 (78.3) 160 (80) 0.705
Dyslipidemia 69 (48.3) 92 (46) 0.680
Diabetes mellitus 44 (30.8) 46 (23) 0.107
Chronic kidney disease 32 (22.4) 29 (14.5) 0.060
Atherosclerosis 23 (16.1) 19 (9.5) 0.067
Obesity 21 (14.7) 20 (10) 0.187
History of neoplasm 15 (10.5) 10 (5.0) 0.048
Peptic ulcer disease 9 (6.3) 12 (6.0) 0.911
Nicotinism 5 (3.5) 8 (4.0) 0.810
Values are displayed as median [with 25th–75th percentiles inter-quartile range] or number (percentage). CDI: Clostridium difficile infection.
https://doi.org/10.1371/journal.pone.0248512.t001
PLOS ONE Acid-base disturbances and Clostridioides difficile infection in patients undergoing cardiac surgery
PLOS ONE | https://doi.org/10.1371/journal.pone.0248512 March 17, 2021 4 / 13
Table 2. Variables of acid-base balance in both analyzed groups.
Variable Patients with CDI (n = 143) Patients without CDI (n = 200) p-value
pH
PREOP 7.422 [7.372–7.445] 7.434 [7.413–7.451] <0.001
INTRA 7.326 [7.269–7.376] 7.336 [7.297–7.380] 0.062
H0 7.317 [7.273–7.369] 7.324 [7.278–7.362] 0.347
H4 7.334 [7.266–7.380] 7.337 [7.306–7.371] 0.170
H8 7.342 [7.278–7.389] 7.354 [7.316–7.379] 0.167
H12 7.343 [7.286–7.375] 7.348 [7.323–7.381] 0.080
PaCO2 (mmHg)
PREOP 36.80 [33.80–40.10] 36.80 [34.60–38.77] 0.721
INTRA 40.90 [36.90–44.60] 41.35 [37.40–44.90] 0.432
H0 40.30 [36.90–44.60] 40.80 [37.95–44.70] 0.129
H4 40.10 [35.80–43.70] 40.70 [37.60–44.10] 0.149
H8 38.90 [36.10–42.10] 39.10 [36.30–42.60] 0.486
H12 39.10 [36.17–43.90] 39.80 [37.10–43.70] 0.211
PaO2 (mmHg)
PREOP 103.0 [82.1–221.0] 87.7 [79.92–100.72] 0.001
INTRA 204.0 [129.0–296.0] 212.0 [136.50–302.75] 0.900
H0 165.0 [140.0–192.0] 174.5 [133.25–202.75] 0.252
H4 163.0 [130.0–182.0] 157.5 [122.50–182.0] 0.436
H8 151.0 [128.0–168.0] 152.0 [125.0–174.0] 0.735
H12 144.0 [116.0–172.0] 151.0 [127.0–171.0] 0.155
BE (mEq/l)
PREOP -0.60 [-2.90–1.50] 0.7 [-0.8–1.8] <0.001
INTRA -5.10 [-7.30– -3.10] -4.0 [-5.8– -1.7] 0.004
H0 -4.90 [-7.10– -2.70] -4.2 [-6.17– -2.1] 0.012
H4 -4.80 [-6.60– -2.30] -3.6 [-5.1– -1.8] 0.001
H8 -4.20 [-6.50– -2.40] -3.4 [-5.2– -1.5] 0.016
H12 -3.95 [-6.95– -2.20] -3.0 [-4.8– -1.5] 0.001
Lactate (mmol/l)
PREOP 1.0 [0.7–1.5] 1.1 [0.9–1.47] 0.126
INTRA 2.3 [1.7–3.7] 2.2 [1.6–2.9] 0.202
H0 2.1 [1.3–3.6] 2.0 [1.32–3.0] 0.217
H4 2.2 [1.3–4.3] 1.9 [1.2–3.0] 0.008
H8 2.2 [1.4–4.1] 1.8 [1.2–3.1] 0.014
H12 2.1 [1.2–4.6] 1.6 [1.1–2.6] 0.001
Lactate > 4 mmol/l, n (%)
PREOP 5 (1.5) 4 (1.2) 0.393
INTRA 27 (7.9) 21 (6.1) 0.027
H0 27 (7.9) 23 (6.7) 0.056
H4 38 (11.1) 28 (8.2) 0.004
H8 36 (10.5) 37 (10.8) 0.143
H12 40 (12.0) 25 (7.5) 0.001
Lactate clearance (%)
0–4 h -1.72 [-42.86–15.00] 6.46 [-18.04–23.08] 0.003
4–8 h -1.47 [-35.48–13.64] 0.0 [-29.85–17.29] 0.500
8–12 h 9.09 [-9.09–23.19] 10.666 [-13.33–31.58] 0.130
0–12 h 0.00 [-69.23–35.00] 15.045 [-23.41–38.46] 0.006
(Continued)
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Patients from the control group had the highest lactate concentration during surgery, then
their lactate levels gradually decreased, whereas lactate clearance progressively increased. In
CDI patients, lactate was also at maximum concentration during the procedure and remained
elevated until the last observation. Additionally, patients with CDI at each of the analyzed time
points, excluding the preoperative period, had higher lactate levels than the control group.
During the postoperative course, in the last three measuring time points, this difference was
significant (p = 0.008, p = 0.014 and p = 0.001, respectively). Severe hyperlactatemia was more
common in CDI patients during the cardiac procedure, 4 h and 12 h after surgery (p = 0.027,
p = 0.004 and p = 0.001, respectively, compared with the control group). The lactate clearance
assessments were lower in patients with CDI during three intervals: between values immedi-
ately and 4 h after surgery, between measurements immediately and 12 h following surgery
and between intraoperative values and 12 h after the procedure (p = 0.003, p = 0.006 and
p = 0.028, respectively, compared with the control group). Patients with CDI also had higher
glucose concentration than patients without CDI during the cardiac procedure, immediately
and 4 h after surgery (p = 0.032, p = 0.040 and p = 0.019, respectively). Moreover, 4 h following
surgery, patients with CDI more often had stress hyperglycemia (p = 0.014) (Table 2).
Perioperative characteristics
There was no difference between analyzed groups in the type of operations (p = 0.448). The
most common surgical procedures were heart valve surgery and coronary artery bypass graft-
ing (for CDI patients: 37.8% and 37.1% and for non-CDI patients: 28.0% and 46.5%, respec-
tively). There was also no difference in the type of perioperative antimicrobial prophylaxis
used in the patients with and without CDI (p = 0.537) (Table 3).
Patients with CDI more frequently underwent emergent surgery, had longer cardiopulmo-
nary bypass time and were more often readmitted to intensive care unit (p< 0.001, p = 0.010
Table 2. (Continued)
Variable Patients with CDI (n = 143) Patients without CDI (n = 200) p-value
INTRA-12 h 6.47 [-64.77–45.75] 25.00 [-15.38–45.45] 0.028
Glucose (mmol/l)
PREOP 6.1 [5.4–7.7] 6.0 [5.4–7.17] 0.600
INTRA 9.4 [7.5–11.5] 8.55 [7.2–10.4] 0.032
H0 9.0 [7.0–10.9] 8.25 [6.9–10.2] 0.040
H4 8.7 [7.1–10.5] 7.95 [6.7–9.4] 0.019
H8 8.6 [7.2–9.9] 8.3 [7.2–9.6] 0.498
H12 8.3 [7.0–10.2] 8.6 [7.2–9.6] 0.758
Glucose >10 mmol/l, n (%)
PREOP 18 (5.25) 17 (4.96) 0.218
INTRA 58 (16.90) 62 (18.07) 0.067
H0 49 (14.28) 52 (15.16) 0.098
H4 46 (13.41) 41 (11.95) 0.014
H8 32 (9.36) 38 (11.11) 0.458
H12 38 (11.41) 37 (11.11) 0.110
Values are displayed as median [with 25th–75th percentiles inter-quartile range] or number (percentage). CDI:
Clostridium difficile infection; H0: measurements taken immediately after surgery; H4: measurements taken 4 h after
surgery; H8: measurements taken 8 h after surgery; H12: measurements taken 12 h after surgery; INTRA:
measurements taken during operation; PREOP: measurements taken before surgery.
https://doi.org/10.1371/journal.pone.0248512.t002
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Table 3. Perioperative data.
Variable Patients with CDI (n = 143) Patients without CDI (n = 200) p-value
Type of surgery, n (%) 0.448
HVS 54 (37.8) 56 (28)
CABG 53 (37.1) 93 (46.5)
Aortic surgery 15 (10.5) 9 (4.5)
CABG + VHS 10 (7.0) 17 (8.5)
CABG + aortic surgery 6 (4.2) 18 (9.0)
MIDCAB 5 (3.5) 7 (3.5)
Timing of surgery, n (%) <0.001
Elective 94 (65.7) 167 (83.5)
Emergent 49 (34.3) 33 (16.5)
Cardiopulmonary bypass time, (min) 106.0 [75.7–158.7] 95.0 [72.0–120.0] 0.010
HVS 123.0 [99.5–163.5] 106.0 [91.0–129.0]
CABG 74.0 [60.0–93.0] 78.0 [64.0–97.0]
Aortic surgery 200.0[120.0–225.0] 137.0 [105.0–211.5]
CABG + VHS 135.0 [115.0–215.0] 126.5 [97.5–147.2]
CABG + aortic surgery 205.0 [99.5–248.5] 102.0 [78.2–126.0]
Aortic cross-clamp time, (min) 66.5 [37.2–91.5] 58.0 [39.2–79.0] 0.144
HVS 76.0 [63.0–98.5] 71.0 [58.0–89.0]
CABG 37.0 [31.0–44.0] 42.0 [33.5–54.5]
Aortic surgery 113.5 [83.0–162.0] 89.0 [75.0–111.5]
CABG + VHS 87.0 [72.5–142.0] 82.0 [69.2–99.2]
CABG + aortic surgery 88.0 [50.5–167.0] 64.5 [29.0–80.0]
Readmission to Intensive Care Unit, n (%) 29 (20.3) 18 (9.0) 0.003
Length of hospital stay, (days) 22 [14.00–41.00] 7 [6.00–9.75] <0.001
Periprocedural prophylaxis based on Cefazolin, n (%) 132 (92) 188 (94) 0.537
Antibiotic other than periprocedural prophylaxis, n (%) 71 (49.6) 51 (25.5) <0.001
Ceftriaxone 45 (31.5) 23 (11.5) <0.001
Vancomycin 20 (14) 21 (10.5) 0.326
Fluoroquinolone 18 (12.6) 15 (7.5) 0.115
Piperacillin/Tazobactam 13 (9.1) 6 (3.0) 0.015
Meropenem 10 (7.0) 6 (3.0) 0.084
Ampicillin 5 (3.5) 6 (3.0) 0.797
Cloxacillin 6 (4.2) 3 (1.5) 0.124
Clindamycin 5 (3.5) 7 (3.5) 0.999
Gentamicin 5 (3.5) 4 (2.0) 0.393
Rifampicin 5 (3.5) 2 (1.0) 0.107
Amoxicillin/Clavulanic acid 3 (2.1) 2 (1.0) 0.403
Teicoplanin 3 (2.1) 1 (0.5) 0.174
Cefuroxime 2 (1.4) 0 (0) 0.093
Colistin 2 (1.4) 1 (0.5) 0.378
Erythromycin 1 (0.7) 0 (0) 0.236
Accompanying infection, n (%) 67 (46.9) 46 (23) <0.001
Wound infection 19 (13.3) 13 (6.5) 0.033
Pneumonia 16 (11.2) 10 (5.0) 0.033
Sepsis 39 (27.3) 25 (12.5) 0.001
(Continued)
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and p = 0.003, respectively, compared with the control group). Additionally, patients with CDI
more often had accompanying infections (p< 0.001), such as wound infection, pneumonia
and sepsis (p = 0.033, p = 0.033 and p = 0.001, respectively, compared with the control group).
These patients also more often received additional antibiotics besides periprocedural antimi-
crobial prophylaxis (p< 0.001, compared with the control group). Ceftriaxone and piperacillin
plus tazobactam were used more frequently in patients with CDI than in non-CD subjects
(p< 0.001 and p = 0.015, respectively). The median length of hospital stay for CDI patients
was 22 days [14.00–41.00] and 7 days [6.00–9.75] for patients without CDI (p< 0.001)
(Table 3).
Multivariate logistic regression analysis revealed that independent risk factors for CDI fol-
lowing cardiac surgery were intraoperative severe hyperlactatemia (OR 2.387, 95% CI 1.155–
4.933, p = 0.019), decreased lactate clearance between values immediately and 12 h after proce-
dure (OR 0.996, 95% CI 0.994–0.999, p = 0.013), increased age (OR 1.045, 95% CI 1.020–1.070,
p< 0.001), emergent surgery (OR 2.755, 95% CI 1.565–4.848, p< 0.001) and use of antibiotics
other than periprocedural prophylaxis (OR 2.778, 95% CI 1.690–4.565, p< 0.001) (Table 4).
Discussion
To the best of our knowledge, this study is the first to evaluate the association between periop-
erative changes in an acid-base balance and CDI incidence in patients after cardiac surgery.
We demonstrated that perioperative increased lactate concentration and decreased lactate
clearance may be independent predictors of occurrence of CDI in the analyzed group of
patients.
Acid-base balance
In this study, patients with CDI had higher lactate levels after surgery in comparison to the
control group. The most significant difference was 12 h following surgery. Most cases of severe
hyperlactatemia also occurred at that time. Moreover, patients with CDI had reduced lactate
clearance, therefore hyperlactatemia was intensified by impaired lactate clearance.
Table 3. (Continued)
Variable Patients with CDI (n = 143) Patients without CDI (n = 200) p-value
Infective endocarditis 5 (3.5) 4 (2.0) 0.393
Values are displayed as median [with 25th–75th percentiles inter-quartile range] or number (percentage). CDI: Clostridium difficile infection; HVS: heart valve surgery;
CABG: coronary artery bypass grafting; MIDCAB: minimally invasive coronary artery bypass.
https://doi.org/10.1371/journal.pone.0248512.t003
Table 4. Multivariate logistic regression for risk of Clostridioides difficile infection.
Variable OR (95% CI) p-value
Age 1.045 (1.020–1.070) <0.001
Emergent surgery 2.755 (1.565–4.848) <0.001
Lactate clearance 0-12H 0.996 (0.994–0.999) 0.013
INTRA Lactate > 4 mmol/l 2.387 (1.155–4.933) 0.019
Antibiotic other than periprocedural prophylaxis 2.778 (1.690–4.565) <0.001
OR: odds ratio; CI: confidence interval; INTRA: measurements taken during operation.
https://doi.org/10.1371/journal.pone.0248512.t004
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There are many potential causes of hyperlactatemia in cardiac surgical patients [8]. One
cause may be tissue hypoperfusion and anaerobic metabolism as a result of inadequate oxygen
delivery during cardiopulmonary bypass. Other reasons of elevated lactate levels may be renal
failure, shock, excessive administration of lactated Ringer’s solution and use of catecholamines
[8]. Hajjar et al. showed that high lactate levels at the end of the cardiac surgery and during the
postoperative period can identify patients with worse postoperative outcomes including a
higher rate of 30-day mortality [16]. Similarly, Maillet et al. proved that lactate threshold of 3
mmol/l at admission to the intensive care unit is able to identify a population at risk of mor-
bidity and mortality after cardiac surgery [17]. Therefore, a targeting therapy to reduce or pre-
vent the increase in lactate levels may improve outcomes of post cardiac surgery [8, 12, 16, 17].
It is also known that early onset hyperlactatemia that develops intraoperatively or within the
first 6 hours after surgery is associated with an increased risk for worse hemodynamic out-
comes, prolonged hospital stay and death, whereas late onset hyperlactatemia is associated
with a benign postoperative course [8]. Our study showed that both early and late onset hyper-
lactatemia may affect the incidence of CDI.
Besides higher lactate levels, patients with CDI also had more negative BE throughout the
perioperative period. An excessive negative BE result indicates an alkaline deficiency and best
reflects metabolic acidosis after cardiac surgery. This may in part be explained by the fact that
lactate is a strong anion that is virtually fully dissociated at physiological pH, and increased lac-
tate concentration reduces the strong ion difference and exerts an acidifying effect on the
blood [8]. It is also known that other underlying causes for acid-base disturbances after cardiac
surgery are manifold and are best displayed by changes in BE [19].
We also demonstrated that patients with increased glucose levels during the operation and
in the early postoperative period were at greater risk for development of CDI. This finding is
consistent with the results of a study by Kirkwood et al., who demonstrated the association of
acute hyperglycemia with an increased risk of CDI [20]. Similarly, Gelijns et al. showed that
stress hyperglycemia was associated with major infection after cardiac surgery [5]. It should be
emphasized that our study did not show that diabetes mellitus is associated with the risk of
CDI. Our study only proved this association for abnormally high blood glucose levels during
the perioperative course. Hyperglycemia induces an impairment of host defenses (e.g., damage
to the neutrophil function, disturbances of the oxidant system and humoral immunity) and
favor the greater frequency of infections [21]. Therefore, guidelines recommend a rigorous
control of glycemia during the postoperative period to reduce surgical infections [22].
Perioperative characteristics
There is significant evidence that many comorbidities increase the risk of CDI development.
Several well-established risk factors such as older age, inflammatory bowel disease, gastrointes-
tinal surgery and immunological incompetence caused by malignant neoplasms, transplanta-
tions, chronic kidney diseases and immunosuppressant therapy are associated with an
increased occurrence of CDI [23–26]. Our results validate these findings and we also showed
that older age and a history of malignant neoplasms were associated with increased risk of
CDI.
Timing of surgery was also an important risk factor for the development of CDI. In our
report the most cases of CDI occurred after emergent surgery. This finding is consistent with
the results of Lemaire et al., who also demonstrated the significant role of emergent cardiac
surgery in the development of CDI [27]. Our results also validate the findings of Gelijns et al.,
who suggested that longer cardiopulmonary bypass time had an impact on major infection
after cardiac surgery including CDI [5].
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In our study, besides periprocedural antimicrobial prophylaxis, some patients received an
additional antibiotic due to accompanying infections other than CDI, and these patients had
greater chance of contracting CDI. Infection of the wound, pneumonia and sepsis were the
most likely factors correlated with CDI occurrence. In part, this finding could be explained by
reduction in immune response to infections and the need for additional antibiotics in such
patients. It is well known that the risk of CDI increases substantially with multiple, prolonged
antibiotic exposure [27, 28]. The pathogenesis of CDI includes disruption of the host micro-
biota, usually with broad-spectrum antibiotics, proliferation of toxins after germination of CD
in the colon, and lack of immune response to the infection [29]. It should be highlighted that
the majority of antibiotics may lead to development of CDI, yet most often it is caused by clin-
damycin, third-generation cephalosporins, fluoroquinolones and broad-spectrum penicillins
[28]. In our research, the analysis of the antibiotics used before the CDI also showed that ceftri-
axone (third-generation cephalosporin) and piperacillin plus tazobactam (broad-spectrum
penicillin) were the antibiotics mostly correlated with the development of postoperative CDI.
A serious approach must be undertaken to reduce unnecessary and excessive administration
of antibiotics in surgical patients thereby preventing the development of CDI.
The majority of reports confirm the finding presented in this study, that prolonged hospi-
talization in the intensive care unit may be a significant risk factor of patients developing CDI
[30, 31]. In our study patients who were readmitted to this ward had greater chance of infec-
tion. Also, Šuljagić et al. showed that duration of intensive care unit stay could be a significant
predictor of CDI in surgical patients [31]. A reason could be that this group of patients were in
a worse general condition, had more comorbidities or co-infections and received additional
antibacterial treatment. There are studies that indicate that CDI affects the length of hospital
stay [20, 27]. We also proved that patients with CDI had longer median postoperative inpatient
stay (from surgery to discharge). Longer hospitalization in CDI patients most likely increases
the cost of hospitalization after cardiac surgery, but unfortunately we have not studied this.
Limitations
This study has several limitations. It was a retrospective research, based on available medical
data. Therefore, the incidence of CDI could be higher due to a lack of information regarding
potential post-discharge diagnosis of the disease. The size of the study group was limited.
Moreover, the relation between CDI and accompanying infections is not clear, because the
time sequence of the development of other infections was not collected. We assumed that
patients who developed an accompanying infection had been treated with antibiotics and
therefore would be more susceptible to CDI. However, it is not known whether CDI or other
infections developed first. At this time, it is clear that there is an association between CDI and
wound infection, pneumonia and sepsis. A prospective study with postoperative follow-up
would identify the time of development of CDI and accompanying infections and determine
causality. Additionally, excess length of hospital stay due to CDI should be interpreted with
caution, because we did not take into account other adverse events and complications (e.g.
other infections, hemodynamic instability) after surgery which may have affected length of
hospital stay. Finally, most importantly, in our study we did not investigate the causes of
hyperlactatemia after cardiac surgery.
Conclusion
In conclusion, our findings indicate that perturbations of the perioperative acid-base balance
increase the risk of CDI in patients after cardiac surgery. Correlation between severe hyperlac-
tatemia and impaired lactate clearance and CDI incidence might suggest that these markers
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